Back

A systematic review and meta-analysis of clinical trials on the impact of sglt2 inhibitors on sleep-disordered breathing: a potential future treatment approach?

30 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Sleep disorders Sleep Apnoea ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kaveh Hosseini

Herlev and Gentofte Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Association between napping and nighttime sleep with the risk of recurrent events in patients with cardiovascular disease: pilot study of the MEDLIFE project
Doctor J. Diaz-Gutierrez (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
The association between cardiorespiratory fitness and obstructive sleep apnea in young and middle-aged adults: a retrospective study
Doctor N. Zheng (Fuzhou, CN)
Abstract Slides Video
Presentation thumbnail
Sex differences in cardiovascular disease and biomarkers in obstructive sleep apnea
Doctor A. Romarheim (Bergen, NO)
Abstract Slides Video
Presentation thumbnail
Biological ageing mediates the associations between disrupted rest-activity circadian rhythms and all-cause and cardiovascular mortality in US adults: NHANES 2011-2014
Miss B. Gu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The heart of sleep: convergence of cardiac electrophysiology and sleep apnea variables in patient monitoring
Ms M. Sargeant (Greenville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Sleep disorders

The Event

Event poster

ESC Congress 2025

30 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of sglt2-inhibitors on polygraphic parameters in elderly patients affected by heart failure and sleep apnea
thumbnail
Congress Presentation
The effect of GLP-1 receptor agonists on obstructive sleep apnea in ambulatory patients with HFpEF, obesity, and type 2 diabetes.
thumbnail
Congress Presentation
Cardiometabolic benefits of dual GLP1-RA and SGLT2i therapy in patients with HFpEF, T2DM, obesity, and obstructive sleep apnea: a prospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources